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contact was less intimate and extensive than that of

the general consultant. The specialist-consultant pro-

vided research expertise in his special area through
actual laboratory work and by keeping the company
abreast of new developments in his area. Swann uses
two University of Wisconsin pharmacologists, Arthur

Loevenhart and Arthur Tatum, as examples of this
type of collaboration. Finally, there were collaborations that emerged to work on a single therapeutic
agent. These were short-term marriages of convenience but often had long-term consequences for both
partners. Swann uses as illustration of this typology
the work of Eli Lilly and Company with University
of Toronto scientists in the development of insulin
and the work of the same company in producing liver
extracts in collaboration with scientists at Harvard

and Rochester. Swann does an excellent job in showing the sticking points of these two Lilly collaborations, building for the insulin story on Michael Bliss's
model study. But the more important lesson is contained in the benefits to both sides. These were fi-

nancial to be sure, but they also brought academic
recognition for the university scientists, including
Nobel Prizes, and near revolutionary changes in research and development at the Indianapolis pharmaceutical company.
John Swann has written a book of large significance to several fields of history. Like all such
books it will serve as a spur to further research by
historians. There is certainly room for other scholars
to add to our understanding of biomédical research
in universities and pharmaceutical companies during
the first four decades of the century, though one sus-

pects that the general outlines of Swann's story will
stand as additional cases are brought to light. Other
historians will need to investigate more thoroughly
than Swann has the business of pharmaceutical man-

ufacturing and marketing. Even more important,
however, is the need to move forward in time. Swann's

book ends in 1940 (with a brief but interesting epilogue about the present), before the immensely important collaborations of World War II, collaborations in which a third player, government, entered
the game. What happened during the 1940s and after
is something scholars and policymakers in many fields
need to know. The research will be difficult. More

archives will need to be opened. More scholars of
Swann's talents will need to understand the importance of this subject. Academic Scientists and the
Pharmaceutical Industry will show the way.- James

H. Madison, Department of History, Indiana
University.

HUMBOLDT AND PHARMACY

Wolfgang-Hagen Hein, Alexander von Humboldt und die Pharmazie, Veröffentlichungen

der Internationalen Gesellschaft für Geschichte

der Pharmacie e.V., Neue Folge, Band 56 (Wissenschaftliche Verlagsgesellschaft, 7000 Stutt-

gart 1, Postfach 40, FRG, 1988; 130 pp.; DM

29).

During the late eighteenth and early nineteenth centuries, when generalists rather than specialists and individuals rather than organizations
dominated the course of scientific development, German naturalist Alexander von Humboldt (1769-1859)
stood out as a leading figure in such diverse yet interrelated fields as geography, geology, botany, medicine, and pharmacy. And despite the massive body
of historical writings on Humboldt, little is known
concerning his contributions to pharmacy and his relationship to the discipline's practitioners. WolfgangHagen Hein ably fills this void in scholarship with
his well-researched Alexander von Humboldt und
die Pharmazie. The significance of this topic to the
history of science should not be underestimated, since

during Humboldt's lifetime pharmacy not only was
transformed in terms of new knowledge concerning
both inorganic compounds and organic natural prod-

ucts, but also because as a discipline it was an important source of manpower for the "new" chemistry
initiated by Lavoisier and others. Beginning with the
turn of the nineteenth century an emerging gener-

ation of chemists left the apothecary shop for the
opportunities of the rapidly developing German university. These former apothecaries- like Heinrich and
Gustav Rose-applied the knowledge and skills gained
during apprenticeship within a new institutional set-

ting and thus provided much of the academic leadership necessary for the gradual evolution of chemical science in Germany in the decades before Justus
von Liebig's spectacular rise to preeminence.
Although the author is aware of the powerful
influence that pharmacy played on chemistry during
the period under consideration he perhaps wisely chose

to restrict his study to Humboldt and his contacts
among pharmacists. As a model of scholarship, Wolfgang-Hagen Hein used George Urdang's study on
Goethe and pharmacy, but a different kind of product

resulted. Unlike Urdang's work, the author had few
primary manuscript materials available and thus was
forced to reconstruct the past in a way in which the
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often expected microscopic detail associated with this
genre of scholarship is missing. Nevertheless, this
absence of diaries and letters can be interpreted as
being a disguised blessing, since by attacking the
periphery rather than the center of his topic Hein has
skillfully produced a splendid collective biography of

these pharmacists contemporary to and associated

order to better understand the relative influence of

these individuals. Using this strategy a sense of the
relative influence that these figures had on Humboldt
and his thinking during the last two decades of his
life crystallizes, and unfortunately this is perhaps the
best one can do since Humboldt's books were de-

stroyed in a fire prior to the auction.

In conclusion, Wolfgang-Hagen Hein's Alex-

with Humboldt.

ander von Humboldt und die Pharmazie is far more

Organizationally the author divided his monograph into three main sections beginning with the
role of pharmacists during Humboldt's formative
years. After discussing the important influence of
Carl Ludwig Willdenow and to a lesser extent that
of Sigismund Friedrich Hermbstaedt, J.F. Göttling,
J.W. Ritter and Nicolas Vanquelin, Hein examined
the significance of Humboldt's 1799-1804 expedition
to the Americas. Humboldt took to Venezuela, Colombia, Ecuador, Mexico, Cuba, and the United States

serves as a useful source of information dealing with
the late eighteenth and early nineteenth century Eu-

a scientific methodology that was in part derived from

DES DILEMMA

his contacts with pharmacists like Willdenow, and
his subsequent inquiries and observations resulted in
the introduction of a host of new substances to West-

ern Europe. For example, Humboldt's systematic
study of the distribution and varieties of Cinchona
Bark led to future investigations concerning its cultivation in India and elsewhere. Other natural products sent to Humboldt's pharmaceutical network in
Europe for analysis and evaluation included Tolu-

than a work on Humboldt. Indeed, it is a study whose
strength lies in the biographies of those pharmacists

in contact with the German naturalist, and thus it

ropean pharmaceutical community.- John A. Heitmann, History Department, University of Dayton.

Roberta Apfel and Susan Fisher, To Do No
Harm: DES and the Dilemma of Modern Medicine (Yale University Press, New Haven, CT,
1984; χ + 199 pp.; price unavailable).

balsam, curare, and guano, and these substances were

Modern pharmacology came into being as a
pivotal science of modern medicine. With its development in twentieth-century America came a mech-

later used to treat a wide variety of ailments and

anism for bringing the laboratory sciences to the bed-

diseases.

side and the pharmacists into the American system
of allopathic medicine.
The authors are medical doctors, psychoanalytically oriented psychiatrists who have worked with

Upon Humboldt's return in 1804 the nature of
his contacts with the pharmacy community subtly
changed since his fame and status were now firmly
established within court circles and scientific com-

munities. Yet Humboldt remained tied to a dynamic
network of pharmacists that served him by funding
valuable sources of information. Emphasis was no
longer placed upon scientific methodology and theory
but rather on the wide ranging factual data necessary
for his written works, including observations and
chemical analyses introduced in his capstone Kosmos.
The mature Humboldt's most significant relationships with pharmacists included ties with Franz August von O'Etzel, Heinrich Rose, Heinrich Robert
Göppert, Johann Christian Poggendorff, Samuel
Heinrich Schwabe, and Hermann Schacht. For Hein
the elucidation of these relationships proved to be
most difficult due to the lack of primary source material, since Humboldt rarely saved letters. To overcome this obstacle the author cleverly employed the
Sotheby's auction catalogue of Humboldt's library in

victims of DES and interviewed the doctors who took

part in the tragedy. They use the accounts by the
actors to give us the experience of DES, through the
lenses of their psychodynamic framework. Thus the
doctor's dilemma is one of a desire to heal and the

painful realization that he violated his moral imperative "to do no harm."

Apfel and Fisher are even more interested in
the psychodrama for the patients who trusted these
doctors. As clinicians, they draw on their own practice with DES mothers and daughters set up for tragedy and disillusion by their (post World War II) desires for children and "normal" family life. This
setting draws us into the experience of mothers who
felt violated by their personal doctors when their science failed, and into the experience of daughters who
felt cheated by their mothers who harmed them even
in utero.
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